SGMT vs. YMAB
Compare and contrast key facts about Sagimet Biosciences Inc. (SGMT) and Y-mAbs Therapeutics, Inc. (YMAB).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SGMT or YMAB.
Correlation
The correlation between SGMT and YMAB is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SGMT vs. YMAB - Performance Comparison
Key characteristics
SGMT:
-0.43
YMAB:
-1.05
SGMT:
-0.09
YMAB:
-1.87
SGMT:
0.99
YMAB:
0.78
SGMT:
-0.53
YMAB:
-0.75
SGMT:
-1.35
YMAB:
-1.58
SGMT:
34.80%
YMAB:
43.79%
SGMT:
109.23%
YMAB:
65.84%
SGMT:
-89.69%
YMAB:
-94.78%
SGMT:
-88.00%
YMAB:
-91.36%
Fundamentals
SGMT:
$71.15M
YMAB:
$212.07M
SGMT:
-$1.45
YMAB:
-$0.67
SGMT:
52.50
YMAB:
2.42
SGMT:
0.46
YMAB:
2.31
SGMT:
$0.00
YMAB:
$67.75M
SGMT:
-$45.69M
YMAB:
-$24.02M
Returns By Period
In the year-to-date period, SGMT achieves a -50.89% return, which is significantly lower than YMAB's -40.10% return.
SGMT
-50.89%
-45.43%
-59.15%
-44.89%
N/A
N/A
YMAB
-40.10%
-6.20%
-67.54%
-69.00%
-32.16%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SGMT vs. YMAB — Risk-Adjusted Performance Rank
SGMT
YMAB
SGMT vs. YMAB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sagimet Biosciences Inc. (SGMT) and Y-mAbs Therapeutics, Inc. (YMAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SGMT vs. YMAB - Dividend Comparison
Neither SGMT nor YMAB has paid dividends to shareholders.
Drawdowns
SGMT vs. YMAB - Drawdown Comparison
The maximum SGMT drawdown since its inception was -89.69%, smaller than the maximum YMAB drawdown of -94.78%. Use the drawdown chart below to compare losses from any high point for SGMT and YMAB. For additional features, visit the drawdowns tool.
Volatility
SGMT vs. YMAB - Volatility Comparison
Sagimet Biosciences Inc. (SGMT) has a higher volatility of 38.97% compared to Y-mAbs Therapeutics, Inc. (YMAB) at 28.51%. This indicates that SGMT's price experiences larger fluctuations and is considered to be riskier than YMAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SGMT vs. YMAB - Financials Comparison
This section allows you to compare key financial metrics between Sagimet Biosciences Inc. and Y-mAbs Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities